When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CLRB - Cellectar Bio up 7% on positive CLR 131 data
Cellectar Biosciences Inc.
Thinly traded nano cap Cellectar Biosciences (CLRB+7.2%) is up on more than a 7x surge in volume, albeit on turnover of only 424K shares, in response to new data from a Phase 2 clinical trial, CLOVER-1, evaluating lead candidate CLR 131 in patients with treatment-resistant B-cell blood cancers.
More news on: Cellectar Biosciences, Inc., Healthcare stocks news, Stocks on the move,